Related Experiment Video
Updated: Oct 2, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses
Chun-Hong Zhu1, Frederick E Domann
1Free Radical & Radiation Biology Program, Department of Radiation Oncology, and Holden Comprehensive Cancer Center, The University of Iowa, Iowa City 52242, USA.
Abstract:
ErbB-3 (HER3) is a member of the epidermal growth factor receptor family. Increasing evidence suggests that elevated expression of ErbB-3 is important for malignancy. In this study, we found that elevated levels of ErbB-3 expression did not occur in the absence of AP-2gamma in a panel of human mammary epithelial and fibroblasts cell lines. In contrast, there was no association between the expression of AP-2alpha or AP-2beta and the level of ErbB-3, or between AP-2alpha and AP-2gamma double positivity and ErbB-3 expression. In co-transfection experiments, exogenous expression of AP-2gamma robustly activated ErbB-3 promoter activity. Moreover, expression of a dominant negative AP-2 protein, AP-2delta (deleted residues 31-117), not only repressed the ErbB-3 promoter activity but also suppressed endogenous ErbB-3 transcription in the ErbB-3 overexpressing cell line MRC-5VA. Overexpression of AP-2A resulted in a decreased proliferation rate and inhibitin of colony formation. Taken together, these data strongly support a role for the AP-2 gene family, in particular, AP-2gamma, in the control of ErbB-3 expression. Interference with the function of transcription factor AP-2 might provide a potential strategy for modulation of the malignant phenotype.
Insights
Transcription factor AP-2gamma (also known as activating enhancer-binding protein 2 gamma) regulates ErbB-3 (also known as HER3) expression. This suggests AP-2 family proteins may be therapeutic targets for reducing malignancy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- ErbB-3 (HER3) is a receptor tyrosine kinase implicated in cancer malignancy.
- The transcription factor AP-2 family plays a role in regulating gene expression.
Purpose of the Study:
- To investigate the role of the AP-2 transcription factor family in regulating ErbB-3 expression.
- To explore the potential of targeting AP-2 for cancer therapy.
Main Methods:
- Analysis of ErbB-3 expression in human mammary epithelial and fibroblast cell lines.
- Co-transfection experiments to assess AP-2gamma's effect on ErbB-3 promoter activity.
- Use of a dominant-negative AP-2 mutant to study endogenous ErbB-3 transcription.
- Cell proliferation and colony formation assays.
Main Results:
- Elevated ErbB-3 expression correlated with AP-2gamma presence, but not AP-2alpha or AP-2beta.
- AP-2gamma robustly activated the ErbB-3 promoter.
- A dominant-negative AP-2 mutant repressed ErbB-3 promoter activity and transcription.
- AP-2gamma overexpression reduced cell proliferation and colony formation.
Conclusions:
- The AP-2 gene family, particularly AP-2gamma, plays a crucial role in controlling ErbB-3 expression.
- Targeting AP-2 function offers a potential strategy for modulating malignant phenotypes by controlling ErbB-3 levels.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Mitogens and the Cell Cycle
Master Transcription Regulators
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Epigenetic Regulation
